HK1050326A1 - Stable liquid preparation comprising sitafloxacin - Google Patents

Stable liquid preparation comprising sitafloxacin

Info

Publication number
HK1050326A1
HK1050326A1 HK03102562A HK03102562A HK1050326A1 HK 1050326 A1 HK1050326 A1 HK 1050326A1 HK 03102562 A HK03102562 A HK 03102562A HK 03102562 A HK03102562 A HK 03102562A HK 1050326 A1 HK1050326 A1 HK 1050326A1
Authority
HK
Hong Kong
Prior art keywords
sitafloxacin
liquid preparation
stable liquid
stable
preparation
Prior art date
Application number
HK03102562A
Other languages
English (en)
Inventor
Araki Masanori
Nakagami Hiroaki
Matsukawa Azusa
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of HK1050326A1 publication Critical patent/HK1050326A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK03102562A 2000-04-24 2003-04-09 Stable liquid preparation comprising sitafloxacin HK1050326A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000127622 2000-04-24
JP2000149812 2000-05-17
PCT/JP2001/003457 WO2001080858A1 (fr) 2000-04-24 2001-04-23 Preparation liquide stable

Publications (1)

Publication Number Publication Date
HK1050326A1 true HK1050326A1 (en) 2003-06-20

Family

ID=26590975

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03102562A HK1050326A1 (en) 2000-04-24 2003-04-09 Stable liquid preparation comprising sitafloxacin

Country Status (20)

Country Link
US (1) US7304075B2 (xx)
EP (1) EP1277471B1 (xx)
JP (1) JP5027975B2 (xx)
KR (1) KR100858228B1 (xx)
CN (1) CN1326524C (xx)
AR (1) AR028028A1 (xx)
AT (1) ATE396729T1 (xx)
AU (1) AU2001248833A1 (xx)
BR (1) BR0110290A (xx)
CA (1) CA2406849C (xx)
DE (1) DE60134221D1 (xx)
DK (1) DK1277471T3 (xx)
ES (1) ES2305065T3 (xx)
HK (1) HK1050326A1 (xx)
MX (1) MXPA02010497A (xx)
NO (1) NO323810B1 (xx)
PT (1) PT1277471E (xx)
RU (1) RU2295342C2 (xx)
TW (1) TWI280131B (xx)
WO (1) WO2001080858A1 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004011001A1 (ja) 2002-07-31 2004-02-05 Senju Pharmaceutical Co., Ltd. 水性液剤および光安定化された水性液剤
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
JP2006151808A (ja) * 2002-12-24 2006-06-15 Dai Ichi Seiyaku Co Ltd 抗菌性水性製剤
EP2055304A1 (en) 2006-08-25 2009-05-06 Astellas Pharma Inc. Stabilized pharmaceutical composition
JP5258331B2 (ja) * 2008-03-03 2013-08-07 ロート製薬株式会社 光安定性が改善されたニューキノロン系抗菌剤含有医薬組成物
WO2010146478A1 (en) * 2009-05-08 2010-12-23 Ranbaxy Laboratories Limited Parenteral composition comprising a fluoroquinolone compound and a nitroimidazole compound
CN101690712B (zh) * 2009-08-25 2011-06-15 武汉武药科技有限公司 一种西他沙星滴眼剂及其制备方法
CN103087042B (zh) * 2012-03-09 2015-02-18 南京优科生物医药有限公司 西他沙星的盐及制药用途
NZ703528A (en) * 2012-06-27 2016-08-26 Takeda Pharmaceutical Liquid preparations of amines and organic acids stabilized by salts
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
AU2014233637A1 (en) 2013-09-09 2015-03-26 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN103622973B (zh) * 2013-12-02 2016-05-11 广东恒诚制药有限公司 一种复方醋酸曲安奈德溶液的制备方法
AT524927A1 (de) * 2021-04-07 2022-10-15 Engel Austria Gmbh Plastifiziereinheit für eine Formgebungsmaschine und Verfahren zum Betreiben einer solchen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537761A1 (de) 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
IL90062A (en) * 1988-04-27 1994-10-07 Daiichi Seiyaku Co History of pyridonecarboxylic acid, their preparation and pharmaceutical preparations containing them
CA2053926A1 (en) 1989-04-28 1990-10-29 Genkichi Ohta Anti-hiv agent
RU2044544C1 (ru) 1989-04-28 1995-09-27 Дайити Фармасьютикал Ко., Лтд Композиция против вируса иммунодефицита человека

Also Published As

Publication number Publication date
AR028028A1 (es) 2003-04-23
BR0110290A (pt) 2003-02-18
DE60134221D1 (de) 2008-07-10
NO20025081L (no) 2002-12-23
CN1326524C (zh) 2007-07-18
KR100858228B1 (ko) 2008-09-12
KR20020089523A (ko) 2002-11-29
US7304075B2 (en) 2007-12-04
CA2406849A1 (en) 2002-10-21
CA2406849C (en) 2007-10-23
PT1277471E (pt) 2008-08-26
NO20025081D0 (no) 2002-10-22
CN1438888A (zh) 2003-08-27
WO2001080858A1 (fr) 2001-11-01
RU2002128631A (ru) 2004-03-27
US20030139436A1 (en) 2003-07-24
ES2305065T3 (es) 2008-11-01
NO323810B1 (no) 2007-07-09
ATE396729T1 (de) 2008-06-15
EP1277471A1 (en) 2003-01-22
TWI280131B (en) 2007-05-01
AU2001248833A1 (en) 2001-11-07
DK1277471T3 (da) 2008-08-11
RU2295342C2 (ru) 2007-03-20
EP1277471A4 (en) 2006-04-12
JP5027975B2 (ja) 2012-09-19
MXPA02010497A (es) 2003-05-14
EP1277471B1 (en) 2008-05-28

Similar Documents

Publication Publication Date Title
GB2359254B (en) Formulation
AU6383901A (en) Liquid formulations
AU2001263839A1 (en) Liquid formulations
HK1050326A1 (en) Stable liquid preparation comprising sitafloxacin
GB0000891D0 (en) Formulation
AP2003002783A0 (en) Medicament containing activted antihtrombin iii
EP1293206A4 (en) LIQUID PREPARATION BASED ON WATER
GB2368735B (en) Oscillator
HK1054508A1 (zh) 新型製劑
AU2001232344A1 (en) Liquid preparation with improved absorbability
HU0000101V0 (en) Multiple-purpose corner-mounting
GB2363371B (en) Liquid measure
CA90858S (en) Teapot
CA95829S (en) Teapot
AU4032601A (en) Liquid metering
GB0023069D0 (en) Formulation
GB0001144D0 (en) Glysophosate formulation
GB0007112D0 (en) Formulation
GB0010846D0 (en) Formulation
GB0004124D0 (en) Formulation
GB0015078D0 (en) Pharmaceutical solution
TW429946U (en) Improved container structure
TW424756U (en) Improved container structure
GB0100735D0 (en) Combustion solution

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130423